Paul Hastings Advises Novella on its Acquisition by Quintiles
August 19, 2013
Atlanta, GA-- Paul Hastings, a leading global law firm, announced today that the firm represented Novella Clinical, a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors, in its agreement to merge with Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services.
The terms of the transaction were not disclosed and the transaction is subject to customary closing conditions.
Healthcare transaction counsel
Paul Hastings is a leading global law firm with a strong presence throughout Asia, Europe, Latin America, and the United States. Through a collaborative approach, entrepreneurial spirit, and commitment to client service, the professionals of Paul Hastings deliver innovative solutions to many of the world’s top financial institutions and Fortune 500 companies.